Total Funding
20
51
Total FundingGrant raised
Growth Score
-4 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
130190
Sedia Biosciences develops and sells medical diagnostic tests and monitoring tools used to battle against pandemics.
- Jason Boone: Vice President Sales and Business DevelopmentPast Role: Floragenex, Vice President
- Roger Gale: Executive Chairman, Co-Founder & CEO
About the Company
It is Sedia's mission to provide more cost effective and accessible diagnostic testing by advancing the widespread use of innovative surveillance and monitoring tools, and point-of-care diagnostic testing.
Our objectives are to become a leader in advancing access to medical care by (1) focusing on point-of-care diagnostics and (2)
developing innovative diagnostic, surveillance and monitoring tools that enable more cost effective deployment of resources by healthcare providers.
With headquarters in Portland, Oregon, USA, Sedia brings together a dedicated team of researchers and scientists that share our common mission - to improve access to medical care around the world by providing innovative diagnostic products.
